How Enlife’s AI Blood Test Could Change Everything for Alzheimer’s Patients
The greatest tragedy of Alzheimer’s disease is not the absence of potential treatments; it is that by the time a patient walks into a doctor’s office with symptoms, the window for meaningful intervention has often already closed. This is the stark reality that Dr Deepak Kumaran Nair, a professor at the Indian Institute of Science (IISc), has spent his career confronting. It is also the problem that his Bengaluru-based deeptech startup, Enlife Research, is now poised to solve with a simple blood test and a powerful artificial intelligence engine .
Read More